Alison Milhous

Director/Board Member at VIVOSIM LABS, INC.

Net worth: 4 219 $ as of 30/09/2026

47 year

97 connections

Health Technology

Commercial Services

Consumer Services

Profile

Alison Tjosvold Milhous is currently an Independent Director at VivoSim Labs, Inc. since 2020 and Vice President-Accounting at Erasca, Inc. since 2021.
Formerly, Ms. Milhous was an Audit Partner at Grant Thornton LLP from 2015 to 2019.
Education includes undergraduate studies at California Polytechnic State University (San Luis Obispo).

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
VIVOSIM LABS INC 0.77%	13/08/2026	19,899 ( 0.77% )	4 219 $	30/09/2026

Alison Milhous active positions

Companies	Position	Start
VIVOSIM LABS, INC.	Director/Board Member	15/09/2020
ERASCA, INC.	Comptroller/Controller/Auditor	01/11/2021

All active positions of Alison Milhous

Former positions of Alison Milhous

Companies	Position	End
Grant Thornton LLP Grant Thornton LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting, assurance, tax and advisory services	Corporate Officer/Principal	01/09/2019

See the detail of Alison Milhous's experience

Education of Alison Milhous

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Alison Milhous's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
VivoSim Labs, Inc. VivoSim Labs, Inc. BiotechnologyHealth Technology Engages in developing and commercializing functional human tissues	Health Technology
Grant Thornton LLP Grant Thornton LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting, assurance, tax and advisory services	Commercial Services
California Polytechnic State University (San Luis Obispo) California Polytechnic State University (San Luis Obispo) Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Erasca, Inc. Erasca, Inc. Pharmaceuticals: MajorHealth Technology Develops, discovers and commercializes therapies for RAS/MAPK pathway-driven cancers	Health Technology